U.S. Online Retail and Ecommerce Stock News

NYSE:NVR
NYSE:NVRConsumer Durables

Institution Exit And Margin Pressure Put NVR’s Resilience To The Test

Brown Brothers Harriman has exited its position in NYSE:NVR, citing declining margins and slowing demand, and pointing to rotation away from homebuilders. NVR’s latest quarter showed rising new orders and mortgage banking income alongside margin compression and a sharp drop in backlog. These developments raise questions about how durable NVR’s business model is as sector conditions get tougher. For you as an investor, this mix of institutional selling and mixed operating data puts NYSE:NVR...
NYSE:UBER
NYSE:UBERTransportation

Uber Robotaxis Go Live In Vegas With Potential Upside For Valuation

Uber Technologies (NYSE:UBER) has expanded commercial robotaxi operations in Las Vegas through its partnership with Motional. Fully electric Motional IONIQ 5 robotaxis are now live for public riders on the Uber app, moving beyond pilot testing. The launch gives everyday Uber users direct access to driverless rides in one of Uber's key U.S. markets. Uber enters this phase of autonomous service with its shares at $73.33 and a 3 year return of 130.7%, alongside a 5 year return of 28.5%. Over...
NYSE:BKV
NYSE:BKVOil and Gas

Is BKV (BKV) Using Its Equity Raise to Quietly Redefine Balance Sheet Strategy?

BKV Corporation recently completed a follow-on public offering of 9,692,089 common shares at US$26.58, raising about US$257.62 million to support general corporate purposes such as working capital, operating expenses and capital expenditures. The offering, which also included shares sold by a major existing stockholder, meaningfully expands BKV’s equity base and could influence how investors assess its balance sheet flexibility and future funding mix. We’ll now examine how this sizeable...
NasdaqGS:AMKR
NasdaqGS:AMKRSemiconductor

How Investors May Respond To Amkor Technology (AMKR) Named NVIDIA Advanced Packaging Partner In AI Supply Chain

In its fourth-quarter 2025 investor letter, iMGP Global Partner highlighted Amkor Technology as a top performer, citing an AI-centered re-rating and enthusiasm around advanced packaging amid robust AI compute demand. Investor interest was further fueled when NVIDIA, in late 2025, identified Amkor as an advanced packaging partner in its broader push to reshore and expand U.S. chip production capacity. We’ll now look at how NVIDIA’s recognition of Amkor as an advanced packaging partner...
NYSE:SNDA
NYSE:SNDAHealthcare

Evaluating Sonida Senior Living (SNDA) Valuation After Strong 1 Year Return And Premium P/S Multiple

Why Sonida Senior Living Is On Investors’ Radar Sonida Senior Living (SNDA) has drawn attention after recent share price swings, with a 1 day return of 4.34% contrasting with a 4.28% decline over the past week. This has prompted closer portfolio reviews. See our latest analysis for Sonida Senior Living. That sharp 1 day share price return of 4.34% comes after a softer 7 day share price return of 4.28%. Sonida Senior Living still has a 90 day share price return of 13.06% and a 1 year total...
NYSE:TWLO
NYSE:TWLOIT

Twilio (TWLO) Valuation Check As Needham Reiterates Buy And KPN RCS Partnership Highlights Messaging And AI Potential

Twilio (TWLO) has been back in focus after Needham reiterated a positive stance on the stock, as investors weigh that optimism in light of Twilio’s new partnership with KPN Netherlands for nationwide RCS Business Messaging. See our latest analysis for Twilio. The recent KPN partnership and upcoming presence at the HIMSS 2026 conference come as Twilio’s share price sits at US$124.50, with a 30 day share price return of 12.73% but a year to date share price decline of 10.02%, while the 1 year...
NasdaqGS:LGN
NasdaqGS:LGNConstruction

Assessing Legence (LGN) Valuation After Recent Share Price Momentum And Revenue Growth Expectations

Event context and recent price performance Legence (LGN) has been on many investors’ screens after recent share price moves, with the stock up around 1% over the past week but showing a loss over the past month. See our latest analysis for Legence. Looking past the recent 5.1% 30 day share price return decline, Legence’s 90 day share price return of 22% and year to date gain of 13.9% suggest that momentum has been building from a higher base around the current US$50.90 share price. If...
NasdaqGS:ACAD
NasdaqGS:ACADBiotechs

Has ACADIA Pharmaceuticals (ACAD) Pullback Opened A New Opportunity For Investors?

If you are wondering whether ACADIA Pharmaceuticals at around US$20.61 is offering good value or just fresh risk, you are in the right place for a closer look at what that price might represent. The share price has seen a 7% decline over the last week, an 8.3% decline over the last month, but a 17.8% return over the last year. This can leave investors questioning whether recent weakness is a setback or a reset after earlier gains. Recent attention on ACADIA has centered on its product...
NYSE:ANF
NYSE:ANFSpecialty Retail

Does Record 2025 Results And Margin Guidance Change The Bull Case For Abercrombie & Fitch (ANF)?

In early March 2026, Abercrombie & Fitch Co. reported past fourth-quarter and full-year 2025 results with record sales of US$1,669.8 million and US$5,266.29 million respectively, even as net income eased to US$172.13 million for the quarter and US$506.92 million for the year, alongside ongoing share repurchases and new store expansion plans. The company coupled this performance with 2026 guidance targeting low single-digit net sales growth, double-digit operating margins of about 12.0% to...
NYSE:NCLH
NYSE:NCLHHospitality

Norwegian Luna Launch Tests Norwegian Cruise Line’s Growth And Valuation Story

Norwegian Cruise Line Holdings (NYSE:NCLH) has introduced its next-generation ship, Norwegian Luna, expanding its fleet with new onboard experiences and itineraries. The ship features updated entertainment, dining concepts, and family-focused amenities, along with itineraries that highlight destinations such as Great Stirrup Cay. This launch reflects a significant product refresh aimed at broadening the guest base, including multi generational families. Norwegian Cruise Line Holdings,...
NasdaqCM:PLSE
NasdaqCM:PLSEMedical Equipment

Is Pulse Biosciences (PLSE) Pricing Make Sense After Recent Volatility And DCF Estimate Gap

If you are wondering whether Pulse Biosciences at around US$21.57 offers good value or is running ahead of itself, you are not alone. The stock has seen mixed recent moves, with an 18.9% return over the last 7 days, a 14.6% decline over the past 30 days, a 61.1% return year to date and a 27.6% return over the past year, while the 3 year return is very large and the 5 year return sits at an 8.5% decline. These moves have come against a backdrop of ongoing attention on Pulse Biosciences and...
NYSE:OGN
NYSE:OGNPharmaceuticals

Is Organon (OGN) Mispriced After A 58% One Year Share Price Slump?

If you are wondering whether Organon is simply beaten down or genuinely cheap, this article will walk through what the current share price might be implying about the company. The stock last closed at US$6.35, with returns of a 3.2% decline over 7 days, a 17.4% decline over 30 days, a 12.3% decline year to date and a 58.1% decline over the past year. This naturally raises questions about how the market is thinking about its risk and potential. Recent coverage around Organon has focused on...
NYSE:EMN
NYSE:EMNChemicals

Eastman Chemical 2026 Self Help Plan Puts Cost Cuts And Cash First

Eastman Chemical (NYSE:EMN) has rolled out a new 2026 self help plan focused on deeper cost reductions and operational efficiency. The plan also targets expanded capital returns, signaling an intention to keep shareholder payouts in focus alongside internal improvements. Management is positioning the initiative as a material shift in how the company runs its business and allocates cash over the next few years. Eastman Chemical is launching this plan at a time when the stock has faced mixed...
NYSE:RCL
NYSE:RCLHospitality

Is It Too Late To Consider Royal Caribbean Cruises (RCL) After Its Strong Share Price Run?

If you are wondering whether Royal Caribbean Cruises at around US$272.54 still offers value or has already run too far, you are not alone. Many investors are now asking what a fair price for the stock really looks like. The share price has seen a 30.4% return over the past year and a very large return over three years, even as the stock has pulled back with a 2.0% decline over the last week, an 18.3% decline over the last month, and a 3.8% decline year to date. Recent headlines around Royal...
NasdaqCM:QUBT
NasdaqCM:QUBTTech

Assessing Quantum Computing (QUBT) Valuation After Recent Share Price Weakness

Quantum Computing stock snapshot after recent moves Quantum Computing (QUBT) has been drawing fresh attention after recent price volatility, with the shares around $7.30 and returns over the month and past 3 months showing double digit declines. See our latest analysis for Quantum Computing. The recent 1 day, 7 day and 30 day share price returns all show declines, and the 90 day share price return of a 39.4% fall contrasts with a very large 3 year total shareholder return. This suggests...
NYSE:MTDR
NYSE:MTDROil and Gas

A Look At Matador Resources (MTDR) Valuation After BMO Outperform Call And Insider Share Purchase

Matador Resources (MTDR) is back on investors’ radar after BMO Capital reaffirmed its positive view on the stock, citing core acreage quality, operational execution, production trends, and recent balance sheet moves. See our latest analysis for Matador Resources. The 1-month share price return of 17.77% and 90-day share price return of 29.11% suggest momentum has been building. The 5-year total shareholder return of 152.21% points to meaningful longer term value creation for investors who...
NasdaqGS:HIMX
NasdaqGS:HIMXSemiconductor

Is It Too Late To Consider Himax Technologies (HIMX) After Recent 33% Weekly Surge?

If you are wondering whether Himax Technologies at around US$9.84 still offers value or if the easy gains are gone, this article unpacks what the current price might be implying. The stock has posted returns of 33.0% over the last 7 days, 19.3% over 30 days, 15.4% year to date and 14.9% over 1 year, with a 3 year return of 46.0% and 5 year return of 1.7% that give important context for any valuation discussion. Recent coverage has focused on Himax's role as a semiconductor player in display...
NYSE:PM
NYSE:PMTobacco

Assessing Philip Morris International’s Valuation After Strong 2025 Smoke Free Growth And 2026 Earnings Guidance

Dividend affirmation and smoke free momentum draw attention Philip Morris International (PM) is back in focus after the board affirmed a regular quarterly dividend of $1.47 per share, alongside recent 2025 results that highlighted expanding smoke free product contributions. See our latest analysis for Philip Morris International. PM’s recent 1-day share price return of 1.55% and 7-day return of 2.75% sit against a 30-day share price return decline of 6.23%, while a 1-year total shareholder...
NasdaqGS:PAYX
NasdaqGS:PAYXProfessional Services

Paychex (PAYX) Valuation Check After Recent Share Price Weakness And Paycor Acquisition Plans

Why Paychex is on investors’ radar now Paychex (PAYX) has drawn renewed attention after recent share performance, with the stock roughly flat over the past month but showing a decline over the past 3 months and year. Against that backdrop, investors are reassessing how the company’s current valuation lines up with its earnings profile, income growth and position in the human capital management and payroll services market. See our latest analysis for Paychex. Recent trading has been choppy,...
NYSE:TRU
NYSE:TRUProfessional Services

Assessing TransUnion (TRU) Valuation After Recent Share Price Volatility

Why TransUnion Is Back on Investors’ Radar TransUnion (TRU) has drawn fresh attention after a recent swing in its share performance, with the stock showing a 0.5% gain over the past day but a 9.6% decline over the past week. This short term volatility comes against a backdrop of mixed returns, including a 2.5% decline over the past month and a 17.4% decline over the past 3 months. This may prompt investors to reassess the company’s fundamentals. See our latest analysis for TransUnion. At...
NYSE:S
NYSE:SSoftware

SentinelOne (S) Earnings Margins Stay Deep In The Red Despite Billion Dollar Revenue Scale

SentinelOne (S) just posted its FY 2026 fourth quarter numbers with revenue of US$271.2 million and a basic EPS loss of US$0.33, alongside trailing twelve month revenue of US$1.0 billion and a basic EPS loss of US$1.37. The company has seen revenue move from US$225.5 million in FY 2025 Q4 to US$271.2 million in FY 2026 Q4, while quarterly basic EPS losses ranged between US$0.18 and US$0.63 over the past year. This sets the stage for investors to weigh solid top line scale against ongoing...
NYSE:PINS
NYSE:PINSInteractive Media and Services

Is Pinterest (PINS) Now An Opportunity After A 31.6% Year To Date Slide?

If you are wondering whether Pinterest is starting to look like value or still a falling knife, you are not alone. A closer look at what the current price implies can help you frame that question. The stock last closed at US$18.18, and recent returns have been weak, with a 9.1% decline over the past week, 4.8% over the last month, and a 31.6% drop year to date, while the 1 year and 5 year returns stand at 43.1% and 75.1% declines respectively. Recent coverage has focused on Pinterest as an...
NYSE:HIG
NYSE:HIGInsurance

Is Hartford (HIG) Offering An Opportunity After Recent Share Price Pullback And Strong Multi Year Gains

If you are wondering whether Hartford Insurance Group's current share price still reflects good value, this article walks through what the numbers actually say rather than relying on headlines or hype. The stock last closed at US$132.93, with a 4.5% decline over the past week and a 6.4% decline over the past month, while the 1 year return stands at 13.7% and the 3 and 5 year returns are 114.1% and 117.3% respectively. Recent coverage around Hartford Insurance Group has focused on the company...
NYSE:LLY
NYSE:LLYPharmaceuticals

Lilly’s China Bet and U.S. Access Push Could Be A Game Changer For Eli Lilly (LLY)

In early March 2026, Eli Lilly announced a US$3.00 billion, decade-long expansion in China centered on local production and supply for its oral obesity pill orforglipron, while simultaneously rolling out its new Employer Connect platform and Zepbound KwikPen to broaden access to obesity treatments in the U.S. Together, this China build-out and employer-focused access model underscore how Lilly is trying to anchor obesity care across both global manufacturing and U.S. benefits design. We’ll...